Pregnant woman with transient diabetes insipidus resistant to 1-desamino-8-D-arginine vasopressin

被引:7
|
作者
Jin-No, Y
Kamiya, Y
Okada, M
Watanabe, O
Ogasawara, M
Fujinami, T
机构
[1] Nagoya City Univ, Sch Med, Dept Internal Med 3, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Nagoya City Univ, Sch Med, Dept Obstet & Gynecol, Nagoya, Aichi 4678601, Japan
关键词
diabetes insipidus; pregnancy; prostaglandin; hydronephrosis; magnetic resonance imaging;
D O I
10.1507/endocrj.45.693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We encountered a pregnant woman with transient diabetes insipidus which developed during the third trimester. A hypertonic saline infusion study did not concentrate the osmolality of urine. Her laboratory data showed hypokalemia, hyperreninemia, an increased concentration of plasma aldosterone and an increased urinary excretion rate of prostaglandin E-2, which resembled hyperprostaglandin E-syndrome. T1-weighted magnetic resonance imaging of the posterior pituitary gland revealed decreased intensity. Polyuria reached 4-6 L daily, and urine osmolality remained dilute despite a lapse of four days since treatment with intranasal 1-desamino-8-D-arginine vasopressin (dDAVP: 10-25 mu g every 12 h). The patient was conservatively managed without medical treatment, then delivered in the 38th week of pregnancy without complication. The osmolality of the patient's urine was higher than that of the plasma when tested 3 days postpartum. The abnormality of magnetic resonance imaging of the posterior pituitary gland disappeared at 6 months after delivery. We consider that subclinical nephrogenic diabetes insipidus in our patient was exacerbated during pregnancy.
引用
收藏
页码:693 / 696
页数:4
相关论文
共 50 条
  • [21] THE SUBCUTANEOUS ADMINISTRATION OF THE VASOPRESSIN ANALOG 1-DESAMINO-8-D-ARGININE VASOPRESSIN IN PATIENTS WITH VONWILLEBRANDS DISEASE AND HEMOPHILIA
    KOHLER, M
    HELLSTERN, P
    REITER, B
    VONBLOHN, G
    WENZEL, E
    KLINISCHE WOCHENSCHRIFT, 1984, 62 (11): : 543 - 548
  • [22] CENTRAL EFFECTS OF VASOPRESSIN AND 1-DESAMINO-8-D-ARGININE VASOPRESSIN (DDAVP) ON INTERLEUKIN-1 FEVER IN THE RAT
    NAYLOR, AM
    GUBITZ, GJ
    DINARELLO, CA
    VEALE, WL
    BRAIN RESEARCH, 1987, 401 (01) : 173 - 177
  • [23] THE INFLUENCE OF INFUSIONS OF 1-DESAMINO-8-D-ARGININE VASOPRESSIN (DDAVP) INVIVO ON THROMBIN GENERATION INVITRO
    IBBOTSON, SH
    DAVIES, JA
    GRANT, PJ
    THROMBOSIS AND HAEMOSTASIS, 1992, 68 (01) : 37 - 39
  • [24] BLEEDING-TIME PROLONGATION WITH STREPTOKINASE AND ITS REDUCTION WITH 1-DESAMINO-8-D-ARGININE VASOPRESSIN
    JOHNSTONE, MT
    ANDREWS, T
    WARE, JA
    RUDD, MA
    GEORGE, D
    WEINSTEIN, M
    LOSCALZO, J
    CIRCULATION, 1990, 82 (06) : 2142 - 2151
  • [25] EFFECT OF 1-DESAMINO-8-D-ARGININE VASOPRESSIN (DDAVP) ON VASOPRESSIN RELEASE AND BLOOD-PRESSURE DURING HEMORRHAGE
    SHIMIZU, K
    NAKAO, A
    ENDOCRINOLOGIA JAPONICA, 1992, 39 (05): : 517 - 523
  • [26] FIBRINOLYTIC RESPONSES TO 1-DESAMINO-8-D-ARGININE-VASOPRESSIN IN PATIENTS WITH CONGENITAL NEPHROGENIC DIABETES-INSIPIDUS
    KNOERS, N
    BROMMER, EJP
    WILLEMS, H
    VANOOST, BA
    MONNENS, LAH
    NEPHRON, 1990, 54 (04): : 322 - 326
  • [27] DDAVP (1-DESAMINO-8-D-ARGININE-VASOPRESSIN)-KINETICS OF PROLONGED ANTIDIURESIS IN CENTRAL DIABETES-INSIPIDUS
    ROBINSON, AG
    SEIF, SM
    CIAROCHI, FF
    ZENSER, TV
    DAVIS, BB
    CLINICAL RESEARCH, 1976, 24 (03): : A277 - A277
  • [28] USE OF 1-DESAMINO-8-D-ARGININE VASOPRESSIN IN MICROSURGICAL RECONSTRUCTION IN A PATIENT WITH VON WILLEBRAND's DISEASE
    Mithani, Suhail K.
    Davis, Jared M.
    Rodriguez, Eduardo D.
    MICROSURGERY, 2011, 31 (02) : 159 - 161
  • [29] 1-DESAMINO-8-D-ARGININE VASOPRESSIN (DESMOPRESSIN) SHORTENS THE BLEEDING-TIME IN STORAGE POOL DEFICIENCY
    NIEUWENHUIS, HK
    SIXMA, JJ
    ANNALS OF INTERNAL MEDICINE, 1988, 108 (01) : 65 - 67
  • [30] ANTIDIURETIC EFFECT AND PHARMACOKINETICS OF ORAL 1-DESAMINO-8-D-ARGININE VASOPRESSIN .1. STUDIES IN ADULTS AND CHILDREN
    WILLIAMS, TDM
    DUNGER, DB
    LYON, CC
    LEWIS, RJ
    TAYLOR, F
    LIGHTMAN, SL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (01): : 129 - 132